These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

362 related articles for article (PubMed ID: 35562979)

  • 1. Epigenetic Modifications and Non-Coding RNA in Diabetes-Mellitus-Induced Coronary Artery Disease: Pathophysiological Link and New Therapeutic Frontiers.
    Prandi FR; Lecis D; Illuminato F; Milite M; Celotto R; Lerakis S; Romeo F; Barillà F
    Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35562979
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epigenetic regulation in diabetic vascular complications.
    Jin J; Wang X; Zhi X; Meng D
    J Mol Endocrinol; 2019 Nov; 63(4):R103-R115. PubMed ID: 31600719
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular Mechanisms and Epigenetic Regulation in Diabetic Cardiomyopathy.
    Mittal A; Garg R; Bahl A; Khullar M
    Front Cardiovasc Med; 2021; 8():725532. PubMed ID: 34977165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Type 2 Diabetes Mellitus and Cardiovascular Disease: Genetic and Epigenetic Links.
    De Rosa S; Arcidiacono B; Chiefari E; Brunetti A; Indolfi C; Foti DP
    Front Endocrinol (Lausanne); 2018; 9():2. PubMed ID: 29387042
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epigenetic mechanisms in coronary artery disease: The current state and prospects.
    Duan L; Liu C; Hu J; Liu Y; Wang J; Chen G; Li Z; Chen H
    Trends Cardiovasc Med; 2018 Jul; 28(5):311-319. PubMed ID: 29366539
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigenetic modifications in metabolic memory: What are the memories, and can we erase them?
    Chen Z; Natarajan R
    Am J Physiol Cell Physiol; 2022 Aug; 323(2):C570-C582. PubMed ID: 35785987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abnormal DNA Methylation Induced by Hyperglycemia Reduces CXCR 4 Gene Expression in CD 34
    Vigorelli V; Resta J; Bianchessi V; Lauri A; Bassetti B; Agrifoglio M; Pesce M; Polvani G; Bonalumi G; Cavallotti L; Alamanni F; Genovese S; Pompilio G; Vinci MC
    J Am Heart Assoc; 2019 May; 8(9):e010012. PubMed ID: 31018749
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antithrombotic Therapy for Atherosclerotic Cardiovascular Disease Risk Mitigation in Patients With Coronary Artery Disease and Diabetes Mellitus.
    Capodanno D; Angiolillo DJ
    Circulation; 2020 Dec; 142(22):2172-2188. PubMed ID: 33253005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epigenetic changes underlie the association between diabetes mellitus and oral diseases.
    Veysari SK; Asghari M; Farshad F; Hodjat M
    Mol Biol Rep; 2023 Aug; 50(8):6987-6996. PubMed ID: 37378745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epigenetic modifications in diabetes.
    Kowluru RA; Mohammad G
    Metabolism; 2022 Jan; 126():154920. PubMed ID: 34715117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epigenetic changes in diabetes.
    Al-Haddad R; Karnib N; Assaad RA; Bilen Y; Emmanuel N; Ghanem A; Younes J; Zibara V; Stephan JS; Sleiman SF
    Neurosci Lett; 2016 Jun; 625():64-9. PubMed ID: 27130819
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epigenetics of hypertension as a risk factor for the development of coronary artery disease in type 2 diabetes mellitus.
    Karabaeva RZ; Vochshenkova TA; Mussin NM; Albayev RK; Kaliyev AA; Tamadon A
    Front Endocrinol (Lausanne); 2024; 15():1365738. PubMed ID: 38836231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Noncoding RNAs involved in DNA methylation and histone methylation, and acetylation in diabetic vascular complications.
    Lu J; Huang Y; Zhang X; Xu Y; Nie S
    Pharmacol Res; 2021 Aug; 170():105520. PubMed ID: 33639232
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic significance of metabolomic biomarkers in patients with diabetes mellitus and coronary artery disease.
    Karagiannidis E; Moysidis DV; Papazoglou AS; Panteris E; Deda O; Stalikas N; Sofidis G; Kartas A; Bekiaridou A; Giannakoulas G; Gika H; Theodoridis G; Sianos G
    Cardiovasc Diabetol; 2022 May; 21(1):70. PubMed ID: 35525960
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epigenetic mechanisms in diabetic complications and metabolic memory.
    Reddy MA; Zhang E; Natarajan R
    Diabetologia; 2015 Mar; 58(3):443-55. PubMed ID: 25481708
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biochemical investigation of rs1801282 variations in PPAR-γ gene and its correlation with risk factors of diabetes mellitus in coronary artery disease.
    Rehman K; Jabeen K; Awan FR; Hussain M; Saddique MA; Akash MSH
    Clin Exp Pharmacol Physiol; 2020 Sep; 47(9):1517-1529. PubMed ID: 32416637
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting epigenetics in diabetic cardiomyopathy: Therapeutic potential of flavonoids.
    Zhou Y; Suo W; Zhang X; Yang Y; Zhao W; Li H; Ni Q
    Biomed Pharmacother; 2023 Jan; 157():114025. PubMed ID: 36399824
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epigenetics and epigenomics in diabetic kidney disease and metabolic memory.
    Kato M; Natarajan R
    Nat Rev Nephrol; 2019 Jun; 15(6):327-345. PubMed ID: 30894700
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emerging Role of Epitranscriptomics in Diabetes Mellitus and Its Complications.
    Geng X; Li Z; Yang Y
    Front Endocrinol (Lausanne); 2022; 13():907060. PubMed ID: 35692393
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathogenesis of Ischemic Stroke: Role of Epigenetic Mechanisms.
    Stanzione R; Cotugno M; Bianchi F; Marchitti S; Forte M; Volpe M; Rubattu S
    Genes (Basel); 2020 Jan; 11(1):. PubMed ID: 31941075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.